Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Curaleaf Holdings (CURLF) EBIT (2019 - 2026)

Curaleaf Holdings has reported EBIT over the past 8 years, most recently at $753000.0 for Q1 2026.

  • For Q1 2026, EBIT fell 91.96% year-over-year to $753000.0; the TTM value through Mar 2026 reached -$308.1 billion, down 1439539.91%, while the annual FY2025 figure was $25.4 million, 2.86% up from the prior year.
  • EBIT for Q1 2026 was $753000.0 at Curaleaf Holdings, up from -$158.9 billion in the prior quarter.
  • Over five years, EBIT peaked at $43.7 million in Q1 2022 and troughed at -$158.9 billion in Q4 2025.
  • A 5-year average of -$18.1 billion and a median of $4.0 million in 2025 define the central range for EBIT.
  • On a YoY basis, EBIT climbed as much as 73636.42% in 2025 and fell as far as 3355292.57% in 2025.
  • Year by year, EBIT stood at -$81.5 million in 2022, then skyrocketed by 100.02% to $13967.0 in 2023, then tumbled by 34001.34% to -$4.7 million in 2024, then crashed by 3355292.57% to -$158.9 billion in 2025, then surged by 100.0% to $753000.0 in 2026.
  • Business Quant data shows EBIT for CURLF at $753000.0 in Q1 2026, -$158.9 billion in Q4 2025, and $4.0 million in Q3 2025.